{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:44:33Z","timestamp":1789969473938,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Schleswig-Holstein Cluster of Excellence in Inflammation Research","award":["DFG EXC 306\/1"],"award-info":[{"award-number":["DFG EXC 306\/1"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.jaad.2010.07.032","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T10:34:50Z","timestamp":1308479690000},"page":"552-558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"title":["Rituximab for treatment-refractory pemphigus and pemphigoid: A\u00a0case series of 17 patients"],"prefix":"10.1016","volume":"65","author":[{"given":"Michael","family":"Kasperkiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iakov","family":"Shimanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2010.07.032_bib1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1749-6632.2009.04744.x","article-title":"Rituximab in severe pemphigus","volume":"1173","author":"Schmidt","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaad.2010.07.032_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/jid.2008.192","article-title":"B-cell-directed therapy for inflammatory skin diseases","volume":"129","author":"Nagel","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2010.07.032_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.intimp.2008.10.004","article-title":"A review of the current use of rituximab in autoimmune diseases","volume":"9","author":"Gurcan","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaad.2010.07.032_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1586\/17469872.3.3.259","article-title":"CD20-directed therapy in autoimmune diseases involving the skin: role of rituximab","volume":"3","author":"Schmidt","year":"2008","journal-title":"Expert Rev Dermatol"},{"key":"10.1016\/j.jaad.2010.07.032_bib5","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2010.07.032_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2010.07.032_bib7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.143.8.1033","article-title":"Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature","volume":"143","author":"Cianchini","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.07.032_bib8","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.07.032_bib9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jaad.2004.06.004","article-title":"Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid","volume":"51","author":"Lazarova","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.07.032_bib10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2133.2006.07646.x","article-title":"Rituximab in autoimmune bullous diseases: mixed responses and adverse effects","volume":"156","author":"Schmidt","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.07.032_bib11","first-page":"731","article-title":"Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab","volume":"6","author":"Taverna","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2010.07.032_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/bjo.2007.129510","article-title":"The use of\u00a0rituximab in refractory mucous membrane pemphigoid with severe ocular involvement","volume":"93","author":"Ross","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaad.2010.07.032_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2340\/00015555-0560","article-title":"Successful treatment of mucous membrane pemphigoid with the anti-CD-20 antibody rituximab","volume":"89","author":"Schumann","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2010.07.032_bib14","first-page":"431","article-title":"Efficacy of rituximab in a case of refractory bullous pemphigoid","volume":"136","author":"Reguiai","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.07.032_bib15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/annonc\/mdn046","article-title":"A new approach on bullous pemphigoid therapy","volume":"19","author":"Saouli","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2010.07.032_bib16","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1525-1470.2008.00751.x","article-title":"Severe bullous pemphigoid in an infant\u2013successful treatment with rituximab","volume":"25","author":"Schulze","year":"2008","journal-title":"Pediatr Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221000873X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221000873X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:19:11Z","timestamp":1759270751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221000873X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S019096221000873X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2010.07.032","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.11732967.14726158","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.11732967.12815071","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab for treatment-refractory pemphigus and pemphigoid: A\u00a0case series of 17 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2010.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}